TOP STORIES

• BUSINESS AZ Aims to Maintain Presence in Oncology Field Via Partnerships until Launch of New Drugs
  November 25, 2013

• BUSINESS Takeda Deploys Cardiovascular, Diabetes Sales Reps for Comprehensive Detailing Activities for Lifestyle Diseases
  November 22, 2013

• BUSINESS Japan Diovan Sales Down 15.7% in July-September: IMS
  November 22, 2013

• REGULATORY JGA President Opposes 50% Rule for Generics, CSIMC Subcommittee Members Disagree
  November 21, 2013

• BUSINESS Japan Now Part of Global PIII Clinical Study for MLN9708: Takeda
  November 21, 2013

• BUSINESS US Pfizer Plans Simultaneous, Global Filing of Five Biosimilars, Eyes Japan Biosimilar Market Entry
  November 20, 2013

• ACADEMIA JAMS’ Draft of Revised Guidelines Ups Ante for COI Disclosures in Clinical Trials
  November 19, 2013

• REGULATORY PAFSC’s 1st Committee on Drugs to Review Astellas’s SGLT-2 Inhibitor Ipragliflozin on Nov. 29
  November 19, 2013

• BUSINESS Takeda, Eisai Earnings Show Signs of Bottoming Out, on Path to Recovery
  November 18, 2013

• BUSINESS Sales of Major Japanese Drug Makers Soar 8.1% on Weak Yen, Steady Japan Business
  November 15, 2013

• REGULATORY Health Ministry Proposes to Set First Generic Prices at Half of Brand Name Drug Prices
  November 14, 2013

• BUSINESS Otsuka Holdings Notches Double-Digit Sales Growth in April-September, Weaker Yen Comes as Boon
  November 14, 2013

• BUSINESS Generic Market Continues to Grow, Three Generic-Only Makers’ Sales Up 8.8%
  November 13, 2013

• BUSINESS GLP-1 Dulaglutide “Catalyst of Growth,” SGLT-2 Empagliflozin Will Be Successful Despite Later Launch: Lilly Diabetes President
  November 12, 2013

• BUSINESS 4 Major Wholesalers’ Operating Margins Stay on Recovery Path, But Average Settlement Rate at Mere 72% at Sept.-End
  November 11, 2013

• BUSINESS Nichi-Iko Pitting Allegra AG against Other Generics, Not Originator: Pres. Tamura
  November 8, 2013

• REGULATORY “Precursor Premium” Proposed at CSIMC Drug Pricing Subcommittee, Yet Further Deliberations Necessary
  November 7, 2013

• REGULATORY Chairman Eto of LDP’s Study Group on Drug Industry Policy Calls for “Balance” in Discussions of Special Price Cuts for Long-Listed Drugs
  November 7, 2013

• BUSINESS Japan ARB Market Gets Back on Growth Track in April-September; No Major Impact from Diovan Woes
  November 6, 2013

• ORGANIZATION Drug Damage Watchdog Presses Criminal Charge against Novartis over Diovan Ads
  November 5, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 222
• 223
• 224
• 225
• 226
• 227
• 228
• 229
• 230
• …
• Next ›
• 最終 »